Infections associated with peripheral venous access devices: A rapid review of the literature
Dr Kelly Shaw, Dr Jennifer Makin and Professor Tania Winzenberg from KP Health and Menzies Institute for Medical Research, University of Tasmania, have prepared this report on behalf of the Australian Commission on Safety and Quality in Health Care.
Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.
The insertion of a peripheral intravenous catheter (PIVC) is one of the most common clinical procedures performed. About 30 million are used in Australia each year, with up to 70% of hospitalised patients requiring a PIVC at some point during their hospital stay. However studies estimate that 4% to 28% of PIVCs inserted are not actually needed, placing the patient unnecessarily at risk of infection.
Despite frequency in PIVC use, complications are reported to be as high as 70%. They can be prone to blockage and dislodgment, cause inflammation of the vein and infection. Nearly half of all first insertion attempts also fail, causing undue pain and anxiety for patients as a result of multiple failed attempts.
To reduce rates of PIVC-related complications, a number of evidence-based strategies have been suggested. Best practice guidelines recommend a range of strategies to reduce risk of complications and increase chances of PIVC success. Despite this, data from Australia and internationally suggest that a significant proportion of patients do not receive care as recommended to optimise use of PIVCs.
A clinical care standard on peripheral intravenous access will aim to support national consistency of best practice for the insertion and management of PIVCs. To inform development of this clinical care standard two literature reviews were undertaken.
The Commission engaged Dr Kelly Shaw, Dr Jennifer Makin and Professor Tania Winzenberg from KP Health and the Menzies Institute for Medical Research, University of Tasmania, to conduct a literature review to better understand the current clinical environment for infection prevention and control methods associated with the insertion and use of PIVCs.